Recombinant prothrombin therapy for hemorrhage

Ended Project Grant Awarded Last action

Award ID
R43HL139105
Recipient
Awarding agency
Obligated
$299,575

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Place of performance
Naperville, IL 60540, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment Recombinant prothrombin therapy for hemorrhage - uncontrolled bleeding remains one of the leading causes of trauma-induced death. Current treatment… $0
Amendment $0
Original award $299,575

Quick answers

Who received award R43HL139105?

R43HL139105 was awarded to Human Cell Co by National Heart Lung and Blood Institute (National Institutes of Health) on August 11, 2017.

How much is award R43HL139105 worth?

$299,575 has been obligated on R43HL139105.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award